[HTML][HTML] Bladder cancer
L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …
Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis
Importance The oligometastatic paradigm postulates that patients with a limited number of
metastases can be treated with ablative local therapy to each site of disease with curative …
metastases can be treated with ablative local therapy to each site of disease with curative …
[HTML][HTML] Treatment of metastatic colorectal cancer: ASCO guideline
Treatment of Metastatic Colorectal Cancer: ASCO Guideline - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
Management of salivary gland malignancy: ASCO guideline
JL Geiger, N Ismaila, B Beadle… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …
other healthcare providers on the management of salivary gland malignancy. METHODS …
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
XS Wang, YF Bai, V Verma, RL Yu… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Adding radiotherapy (RT) to systemic therapy improves progression-free
survival (PFS) and overall survival (OS) in oligometastatic non-small cell lung cancer …
survival (PFS) and overall survival (OS) in oligometastatic non-small cell lung cancer …
Managing metastatic melanoma in 2022: a clinical review
B Switzer, I Puzanov, JJ Skitzki, L Hamad… - JCO Oncology …, 2022 - ascopubs.org
Cutaneous melanoma remains the most lethal of the primary cutaneous neoplasms, and
although the incidence of primary melanoma continues to rise, the mortality from metastatic …
although the incidence of primary melanoma continues to rise, the mortality from metastatic …
[HTML][HTML] The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes
Purpose Long-term randomized data assessing the effect of ablative therapies in patients
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …
The abscopal effect: a review of pre-clinical and clinical advances
Radiotherapy has been used for more than a hundred years to cure or locally control tumors.
Regression of tumors outside of the irradiated field was occasionally observed and is known …
Regression of tumors outside of the irradiated field was occasionally observed and is known …
Nivolumab in combination with stereotactic body radiotherapy in pretreated patients with metastatic renal cell carcinoma. Results of the phase II NIVES study
Background Nivolumab showed an overall survival (OS) benefit in pretreated metastatic
renal cell carcinoma (mRCC). The role of stereotactic body radiotherapy (SBRT) in mRCC …
renal cell carcinoma (mRCC). The role of stereotactic body radiotherapy (SBRT) in mRCC …